Skip to main content

Medpace Holdings, Inc. (MEDP)

NASDAQ: MEDP · IEX Real-Time Price · USD
206.14 -5.09 (-2.41%)
Dec 3, 2021 4:00 PM EST - Market closed

Company Description

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services.

The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials.

Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Medpace Holdings, Inc.
Medpace Holdings Logo
CountryUnited States
Founded1992
IPO DateAug 11, 2016
IndustryLife Sciences Tools & Services
SectorHealth Care
Employees4,400
CEOAugust Troendle

Contact Details

Address:
5375 Medpace Way
Cincinnati, Ohio 45227-1543
United States
Phone513 579 9911
Websitemedpace.com

Stock Details

Ticker SymbolMEDP
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code0001668397

Key Executives

NamePosition
Dr. August James Troendle M.D.Chairman and Chief Executive Officer
Jesse J. Geiger BBA, CPAPresident
Susan E. BurwigExecutive Vice President of Operations
Stephen P. EwaldChief Compliance Officer, General Counsel and Corporate Secretary
Kevin M. BradyChief Financial Officer and Treasurer
Brandon EbkenChief Information Officer
Lauren MorrisAssociate Director of Investors Relations
Todd MeyersVice President of Business Development and Marketing
Weimin Gai MSSenior Vice President of Biometrics
Daniel O'LearySenior Vice President of Medical Department

Latest SEC Filings

DateTypeTitle
Dec 3, 20214Statement of changes in beneficial ownership of securities
Dec 3, 20214Statement of changes in beneficial ownership of securities
Dec 1, 20214Statement of changes in beneficial ownership of securities
Dec 1, 20214Statement of changes in beneficial ownership of securities
Nov 29, 20214Statement of changes in beneficial ownership of securities
Nov 29, 20214Statement of changes in beneficial ownership of securities
Nov 24, 20214Statement of changes in beneficial ownership of securities
Nov 24, 20214Statement of changes in beneficial ownership of securities
Nov 5, 20214Statement of changes in beneficial ownership of securities
Nov 4, 20214Statement of changes in beneficial ownership of securities
View All SEC Filings